Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0202075
Disease: 17 Hydroxyprogesterone measurement
17 Hydroxyprogesterone measurement
0.100 GeneticVariation phenotype GWASCAT Genetic Association Study of Eight Steroid Hormones and Implications for Sexual Dimorphism of Coronary Artery Disease. 31169883 2019
CUI: C0852654
Disease: 21-hydroxylase deficiency
21-hydroxylase deficiency
0.080 Biomarker disease BEFREE A partial recessive model with no recombination between 21-OHD and HLA-B fitted the data better than did a complete recessive model with approximately 0.5% recombination between 21-OHD and HLA-B. 3259403 1988
CUI: C0852654
Disease: 21-hydroxylase deficiency
21-hydroxylase deficiency
0.080 Biomarker disease BEFREE We confirm that late-onset of 21OHD is an autosomal recessive disease linked to HLA-B; there is in fact biochemical evidence of mild 21OHD in patients and in their HLA identical sibs and 17-hydroxyprogesterone levels in the range of heterozygotes for classical 21OHD in parents and sibs predicted by HLA to be carriers. 3009598 1986
CUI: C0852654
Disease: 21-hydroxylase deficiency
21-hydroxylase deficiency
0.080 GeneticVariation disease BEFREE The HLA-B locus-specific DNA-probe, pHLA-1.1, can be used for diagnosis and genotyping of individuals from families with 21-hydroxylase deficiency. 2897792 1988
CUI: C0852654
Disease: 21-hydroxylase deficiency
21-hydroxylase deficiency
0.080 GeneticVariation disease BEFREE The 21-hydroxylase deficiency is genetically linked to the human leukocyte antigen (HLA) complex; in addition, nonclassical and classical 21-hydroxylase deficiency have each been shown to be in genetic linkage disequilibrium with specific HLA-B antigens. 6372675 1984
CUI: C0852654
Disease: 21-hydroxylase deficiency
21-hydroxylase deficiency
0.080 GeneticVariation disease BEFREE Here, we have used HLA-B genotype data in families containing multiple members affected with nonclassical 21-hydroxylase deficiency together with the results of quantitative hormonal tests to arrive at estimates of gene and disease frequencies for this disorder. 9556656 1985
CUI: C0852654
Disease: 21-hydroxylase deficiency
21-hydroxylase deficiency
0.080 Biomarker disease BEFREE Close genetic linkage between HLA-B and 21-hydroxylase deficiency was thus established. 692595 1978
CUI: C0852654
Disease: 21-hydroxylase deficiency
21-hydroxylase deficiency
0.080 GeneticVariation disease BEFREE Seven of the eight sibling pairs concordant for 21-hydroxylase deficiency had pairwise identical TaqI HLA-B-DRB-DQA-DQB haplotypes. 1977680 1990
CUI: C0852654
Disease: 21-hydroxylase deficiency
21-hydroxylase deficiency
0.080 GeneticVariation disease BEFREE The hormonal and genetic linkage studies indicate that the late-onset (symptomatic) form of 21-hydroxylase deficiency, like the cryptic (asymptomatic) and classical forms of 21-hydroxylase deficiency, is transmitted by an autosomal recessive gene which is linked to HLA-B. 6288753 1982
CUI: C0000737
Disease: Abdominal Pain
Abdominal Pain
0.100 Biomarker phenotype HPO
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.010 Biomarker phenotype BEFREE On the basis of this and other findings such as increased numbers of CD3+ and CD4+ cells, an increased ratio of CD4+/CD8+ cells, and a reduced level of suppressor cell activity in schizophrenia and endogenous depression, we investigated the influence of the human leukocyte antigen-Class I (HLA-A, HLA-B, HLA-C) system on the altered immune function and evaluated the relationship to immune function of a family history of psychiatric disorders. 8272443 1993
CUI: C2132198
Disease: Abnormal blistering of the skin
Abnormal blistering of the skin
0.100 Biomarker phenotype HPO
CUI: C0231557
Disease: Abnormal bone formation
Abnormal bone formation
0.010 Biomarker disease BEFREE Ankylosing spondylitis (AS) is an autoimmune condition characterized by chronic inflammation and abnormal ossification as the primary features of the disease. 30816502 2019
CUI: C4021662
Disease: Abnormal endocardium morphology
Abnormal endocardium morphology
0.100 Biomarker phenotype HPO
CUI: C4025758
Disease: Abnormal myocardium morphology
Abnormal myocardium morphology
0.100 Biomarker phenotype HPO
CUI: C1837388
Disease: Abnormal pattern of respiration
Abnormal pattern of respiration
0.100 Biomarker phenotype HPO
CUI: C3164445
Disease: Abnormality of aortic valve
Abnormality of aortic valve
0.100 Biomarker disease HPO
CUI: C4025726
Disease: Abnormality of the pleura
Abnormality of the pleura
0.100 Biomarker disease HPO
CUI: C4025826
Disease: Abnormality of the urethra
Abnormality of the urethra
0.100 Biomarker disease HPO
CUI: C0000887
Disease: Acantholysis
Acantholysis
0.100 Biomarker phenotype HPO
CUI: C0702166
Disease: Acne
Acne
0.100 Biomarker disease HPO
CUI: C0271907
Disease: Acquired aplastic anemia
Acquired aplastic anemia
0.030 GeneticVariation disease BEFREE The markedly high prevalence of leukocytes lacking HLA-B4002 as a result of either 6pLOH or structural gene mutations, or both, suggests that antigen presentation by hematopoietic stem/progenitor cells to cytotoxic T cells via the HLA-B allele plays a critical role in the pathogenesis of AA. 28232583 2017
CUI: C0271907
Disease: Acquired aplastic anemia
Acquired aplastic anemia
0.030 GeneticVariation disease BEFREE Correlations between HLA-A, HLA-B and HLA-DRB1 allele polymorphisms and childhood susceptibility to acquired aplastic anemia. 22572536 2012
CUI: C0271907
Disease: Acquired aplastic anemia
Acquired aplastic anemia
0.030 GeneticVariation disease BEFREE Novel deletion mutation of HLA-B*40:02 gene in acquired aplastic anemia. 28025876 2017
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
Acquired Immunodeficiency Syndrome
0.140 Biomarker group LHGDN Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. 12134147 2002